CN102666873A - 用于高效率蛋白质表达的分泌蛋白质生物标记物 - Google Patents

用于高效率蛋白质表达的分泌蛋白质生物标记物 Download PDF

Info

Publication number
CN102666873A
CN102666873A CN2010800503369A CN201080050336A CN102666873A CN 102666873 A CN102666873 A CN 102666873A CN 2010800503369 A CN2010800503369 A CN 2010800503369A CN 201080050336 A CN201080050336 A CN 201080050336A CN 102666873 A CN102666873 A CN 102666873A
Authority
CN
China
Prior art keywords
protein
subunit
cell
precursor
biomarker
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2010800503369A
Other languages
English (en)
Chinese (zh)
Inventor
P.霍斯勒
I.R.科雷亚
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AbbVie Inc
Original Assignee
Abbott GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott GmbH and Co KG filed Critical Abbott GmbH and Co KG
Publication of CN102666873A publication Critical patent/CN102666873A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5023Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966Animal cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CN2010800503369A 2009-11-09 2010-11-09 用于高效率蛋白质表达的分泌蛋白质生物标记物 Pending CN102666873A (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US25952709P 2009-11-09 2009-11-09
US61/259527 2009-11-09
US12/941347 2010-11-08
US12/941,347 US8524458B2 (en) 2009-11-09 2010-11-08 Secretory protein biomarkers for high efficiency protein expression
PCT/US2010/055953 WO2011057239A2 (en) 2009-11-09 2010-11-09 Secretory protein biomarkers for high efficiency protein expression

Publications (1)

Publication Number Publication Date
CN102666873A true CN102666873A (zh) 2012-09-12

Family

ID=43431809

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010800503369A Pending CN102666873A (zh) 2009-11-09 2010-11-09 用于高效率蛋白质表达的分泌蛋白质生物标记物

Country Status (14)

Country Link
US (2) US8524458B2 (enExample)
EP (1) EP2499254A2 (enExample)
JP (1) JP2013510324A (enExample)
KR (1) KR20120115494A (enExample)
CN (1) CN102666873A (enExample)
AU (1) AU2010314922A1 (enExample)
BR (1) BR112012010976A2 (enExample)
CA (1) CA2778254A1 (enExample)
IL (1) IL219518A0 (enExample)
IN (1) IN2012DN03358A (enExample)
MX (1) MX2012005380A (enExample)
RU (1) RU2012124114A (enExample)
WO (1) WO2011057239A2 (enExample)
ZA (1) ZA201202966B (enExample)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108467890A (zh) * 2018-05-02 2018-08-31 首都医科大学附属北京天坛医院 Vat1基因及vat1基因的干扰物的应用和应用vat1基因的产品
CN109470756A (zh) * 2018-10-11 2019-03-15 昆明理工大学 测定14-3-3蛋白与质膜H+-ATPase蛋白互作的电化学方法
JP2019527815A (ja) * 2016-06-06 2019-10-03 マックス−プランク−ゲゼルシャフト・ツア・フェルデルング・デア・ヴィッセンシャフテン・エー・ファオ 生体高分子複合体の精製のための方法
CN117099743A (zh) * 2023-07-11 2023-11-24 吉林大学 一种snx6基因不表达的异种移植供体及制备方法

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6507542B2 (ja) * 2014-09-22 2019-05-08 東洋紡株式会社 バイオマーカーを用いた組換えタンパク質生産量の予測方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008054514A2 (en) * 2006-04-21 2008-05-08 Wyeth Differential expression profiling analysis of cell culture phenotypes and the uses thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE30985E (en) 1978-01-01 1982-06-29 Serum-free cell culture media
US4560655A (en) 1982-12-16 1985-12-24 Immunex Corporation Serum-free cell culture medium and process for making same
US4657866A (en) 1982-12-21 1987-04-14 Sudhir Kumar Serum-free, synthetic, completely chemically defined tissue culture media
US4767704A (en) 1983-10-07 1988-08-30 Columbia University In The City Of New York Protein-free culture medium
GB8516415D0 (en) 1985-06-28 1985-07-31 Celltech Ltd Culture of animal cells
US4927762A (en) 1986-04-01 1990-05-22 Cell Enterprises, Inc. Cell culture medium with antioxidant
US5302517A (en) * 1987-06-16 1994-04-12 The Board Of Regents Of The University Of Nebraska Method of controlling the expression of a gene in a cell culture, cell culture vector used in the method and method of making the vector
EP0435911B1 (en) 1988-09-23 1996-03-13 Cetus Oncology Corporation Cell culture medium for enhanced cell growth, culture longevity and product expression
US5122469A (en) 1990-10-03 1992-06-16 Genentech, Inc. Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
US20050272055A1 (en) * 2000-02-01 2005-12-08 Rina Das Method of treating lethal shock induced by toxic agents and diagnosing exposure to toxic agents by measuring distinct pattern in the levels of expression of specific genes
US8242057B2 (en) * 2006-06-26 2012-08-14 Cleveland Biolabs, Inc. Methods for identifying modulators of apoptosis
JP2011522265A (ja) * 2008-06-04 2011-07-28 プロテオシス アクチエンゲゼルシャフト 化学物質の発生毒性及び胚性毒性のinvitro試験のためのタンパク質バイオマーカー

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008054514A2 (en) * 2006-04-21 2008-05-08 Wyeth Differential expression profiling analysis of cell culture phenotypes and the uses thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
王巧侠等: "热休克蛋白70和糖调节蛋白94 在人胃癌细胞BGC-823中的表达", 《陕西医学杂志》 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019527815A (ja) * 2016-06-06 2019-10-03 マックス−プランク−ゲゼルシャフト・ツア・フェルデルング・デア・ヴィッセンシャフテン・エー・ファオ 生体高分子複合体の精製のための方法
US11401301B2 (en) 2016-06-06 2022-08-02 Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V. Method for the purification of biological macromolecular complexes
CN108467890A (zh) * 2018-05-02 2018-08-31 首都医科大学附属北京天坛医院 Vat1基因及vat1基因的干扰物的应用和应用vat1基因的产品
CN109470756A (zh) * 2018-10-11 2019-03-15 昆明理工大学 测定14-3-3蛋白与质膜H+-ATPase蛋白互作的电化学方法
CN109470756B (zh) * 2018-10-11 2020-08-25 昆明理工大学 测定14-3-3蛋白与质膜H+-ATPase蛋白互作的电化学方法
CN117099743A (zh) * 2023-07-11 2023-11-24 吉林大学 一种snx6基因不表达的异种移植供体及制备方法

Also Published As

Publication number Publication date
US8524458B2 (en) 2013-09-03
MX2012005380A (es) 2012-05-29
AU2010314922A1 (en) 2012-05-31
WO2011057239A3 (en) 2011-06-30
JP2013510324A (ja) 2013-03-21
KR20120115494A (ko) 2012-10-18
BR112012010976A2 (pt) 2016-08-16
WO2011057239A2 (en) 2011-05-12
US20140004531A1 (en) 2014-01-02
RU2012124114A (ru) 2013-12-20
IN2012DN03358A (enExample) 2015-10-23
EP2499254A2 (en) 2012-09-19
IL219518A0 (en) 2012-06-28
CA2778254A1 (en) 2011-05-12
US20110236906A1 (en) 2011-09-29
ZA201202966B (en) 2012-12-27

Similar Documents

Publication Publication Date Title
Budnik et al. SCoPE-MS: mass spectrometry of single mammalian cells quantifies proteome heterogeneity during cell differentiation
Evers et al. Deciphering metabolic heterogeneity by single-cell analysis
Boersema et al. Proteomics beyond large-scale protein expression analysis
Webb et al. Modified MuDPIT separation identified 4488 proteins in a system-wide analysis of quiescence in yeast
Baharvand et al. Concise review: trends in stem cell proteomics
JP5682986B2 (ja) 質量分析における安定同位体標識標的ペプチド断片の作製方法
US11719703B2 (en) Mass spectrometry technique for single cell proteomics
Huang et al. SNaPP: simplified nanoproteomics platform for reproducible global proteomic analysis of nanogram protein quantities
Liu et al. Deep profiling of microgram-scale proteome by tandem mass tag mass spectrometry
Dong et al. A “tagless” strategy for identification of stable protein complexes genome-wide by multidimensional orthogonal chromatographic separation and iTRAQ reagent tracking
Zhu et al. Capillary isoelectric focusing-tandem mass spectrometry and reversed-phase liquid chromatography-tandem mass spectrometry for quantitative proteomic analysis of differentiating PC12 cells by eight-plex isobaric tags for relative and absolute quantification
US20140004531A1 (en) Secretory Protein Biomarkers For High Efficiency Protein Expression
Franciosa et al. Proteomics to study cancer immunity and improve treatment
Muschong et al. Improvement of Workflows and Assay Reproducibility by The Introduction of “Assay-Ready” Culturing of MDCK Cells for Transport Studies
Brenes et al. Proteomic and functional comparison between human induced and embryonic stem cells
Dörrbaum et al. Dynamic SILAC to determine protein turnover in neurons and glia
Yan et al. Ribosomal proteomics: Strategies, approaches, and perspectives
Wang et al. Proteomic studies of stem cells
Schmidt et al. Quantitative peptide and protein profiling by mass spectrometry
Bortecen Analyzing the individual contributions of translation initiation factors to shaping the proteome of cancer cells
TW201140050A (en) Secretory protein biomarkers for high efficiency protein expression
Feola et al. PeptiCHIP: a novel microfluidic-based chip platform for tumour antigen landscape identification
Goeminne Statistical methods for differential proteomics at peptide and protein level
Baker et al. Single-Cell Protein Assays in Context: From 2D to 3D and In Situ Analysis
Florczak Quantitative Analysis of Proteome Dynamics in Chinese Hamster Ovary Cells

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Owner name: ABBVIE COMPANY

Free format text: FORMER OWNER: ABBOTT GMBH. + CO. KG

Effective date: 20130619

C41 Transfer of patent application or patent right or utility model
TA01 Transfer of patent application right

Effective date of registration: 20130619

Address after: Illinois State

Applicant after: ABBVIE company

Address before: Illinois State

Applicant before: Abbott GmbH. & Co. Kg

C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20120912